Literature DB >> 16498599

Collageneous matrix coatings on titanium implants modified with decorin and chondroitin sulfate: characterization and influence on osteoblastic cells.

Susanne Bierbaum1, Timothy Douglas, Thomas Hanke, Dieter Scharnweber, Sonja Tippelt, Thomas K Monsees, Richard H W Funk, Hartmut Worch.   

Abstract

Studies in developmental and cell biology have established the fact that responses of cells are influenced to a large degree by morphology and composition of the extracellular matrix. Goal of this work is to use this basic principle to improve the biological acceptance of implants by modifying the surfaces with components of the extracellular matrix (ECM), utilizing the natural self-assembly potential of collagen in combination with further ECM components in close analogy to the situation in vivo. Aiming at load-bearing applications in bone contact, collagen type I in combination with the proteoglycan decorin and the glycosaminoglycan chondroitin sulfate (CS) was used; fibrillogenesis, fibril morphology, and adsorption of differently composed fibrils onto titanium were assessed. Both decorin and CS could be integrated into the fibrils during fibrillogenesis, the amount bound respectively desorbed depending on the ionic strength of fibrillogenesis buffer. Including decorin always resulted in a significant decrease of fibril diameter, CS in only a slight decrease or even increase, depending on the collagen preparation used. No significant changes in adsorption to titanium could be detected. Osteoblastic cells showed different reactions for cytoskeletal arrangement and osteopontin expression depending on the composition of the ECM, with CS enhancing the osteoblast phenotype.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16498599     DOI: 10.1002/jbm.a.30572

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  21 in total

1.  Adjusting the chlorhexidine content of calcium phosphate coatings by electrochemically assisted co-deposition from aqueous solutions.

Authors:  D Scharnweber; M Flössel; R Born; H Worch
Journal:  J Mater Sci Mater Med       Date:  2007-02       Impact factor: 3.896

2.  Collagen-binding peptidoglycans: a biomimetic approach to modulate collagen fibrillogenesis for tissue engineering applications.

Authors:  John E Paderi; Rizaldi Sistiabudi; Albena Ivanisevic; Alyssa Panitch
Journal:  Tissue Eng Part A       Date:  2009-10       Impact factor: 3.845

3.  Coating with artificial matrices from collagen and sulfated hyaluronan influences the osseointegration of dental implants.

Authors:  Matthias C Schulz; Paula Korn; Bernd Stadlinger; Ursula Range; Stephanie Möller; Jana Becher; Matthias Schnabelrauch; Ronald Mai; Dieter Scharnweber; Uwe Eckelt; Vera Hintze
Journal:  J Mater Sci Mater Med       Date:  2013-10-11       Impact factor: 3.896

4.  A role for decorin in controlling proliferation, adhesion, and migration of murine embryonic fibroblasts.

Authors:  Z Ferdous; S B Peterson; H Tseng; D K Anderson; R V Iozzo; K J Grande-Allen
Journal:  J Biomed Mater Res A       Date:  2010-05       Impact factor: 4.396

Review 5.  Regenerative potential of glycosaminoglycans for skin and bone.

Authors:  Juliane Salbach; Tilman D Rachner; Martina Rauner; Ute Hempel; Ulf Anderegg; Sandra Franz; Jan-Christoph Simon; Lorenz C Hofbauer
Journal:  J Mol Med (Berl)       Date:  2011-12-21       Impact factor: 4.599

6.  Glucuronic acid and phosphoserine act as mineralization mediators of collagen I based biomimetic substrates.

Authors:  Ricardo Tejero; Susanne Bierbaum; Timothy Douglas; Antje Reinstorf; Hartmut Worch; Dieter Scharnweber
Journal:  J Mater Sci Mater Med       Date:  2009-11-26       Impact factor: 3.896

7.  Expression of versican isoform V3 in the absence of ascorbate improves elastogenesis in engineered vascular constructs.

Authors:  Paul A Keire; Nicolas L'Heureux; Robert B Vernon; Mervyn J Merrilees; Barry Starcher; Elena Okon; Nathalie Dusserre; Todd N McAllister; Thomas N Wight
Journal:  Tissue Eng Part A       Date:  2010-02       Impact factor: 3.845

8.  Characterization of collagen II fibrils containing biglycan and their effect as a coating on osteoblast adhesion and proliferation.

Authors:  Timothy Douglas; Sascha Heinemann; Ute Hempel; Carolin Mietrach; Christiane Knieb; Susanne Bierbaum; Dieter Scharnweber; Hartmut Worch
Journal:  J Mater Sci Mater Med       Date:  2007-09-13       Impact factor: 3.896

9.  Effect of biological implant surface coatings on bone formation, applying collagen, proteoglycans, glycosaminoglycans and growth factors.

Authors:  Bernd Stadlinger; Eckart Pilling; Ronald Mai; Susanne Bierbaum; Ricardo Berhardt; Dieter Scharnweber; Uwe Eckelt
Journal:  J Mater Sci Mater Med       Date:  2007-08-15       Impact factor: 3.896

Review 10.  Application of bone growth factors--the potential of different carrier systems.

Authors:  Henning Schliephake
Journal:  Oral Maxillofac Surg       Date:  2010-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.